Does Semaglutide Burn Belly Fat — and How Does That Actually Work?

Step 1: understand what semaglutide is actually doing in your body

Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that signals fullness to the brain, slows how quickly food leaves the stomach, and reduces appetite. The result, over weeks and months, is that most people eat considerably less without feeling deprived in the way a conventional calorie-restricted diet often demands.

Fat is lost because the body draws on its energy stores when intake falls below expenditure. That process is not selective by anatomy, your body does not receive a memo telling it to start with the abdomen. What clinical research does show, though, is that people taking semaglutide 2.4mg lost significant amounts of both total and visceral fat. Visceral fat, the kind packed around your liver, intestines and other abdominal organs, is metabolically active and strongly associated with type 2 diabetes, heart disease and other conditions. Losing it matters beyond how a waistband fits.

The STEP 1 trial published in the New England Journal of Medicine randomised nearly 2,000 adults with obesity and reported around 15% average body-weight reduction at 68 weeks with 2.4mg semaglutide alongside lifestyle changes. Waist-circumference reductions were consistent with that scale of loss. If you want a broader look at how semaglutide burns fat across the body, the mechanism is explored in more detail there.

Step 2: set realistic expectations about where fat comes from

A common question our prescribers hear is whether the belly goes first. The honest answer is: it varies, and nobody can guarantee your body's sequence. What large trials do consistently show is that abdominal circumference shrinks alongside total weight, often proportionally or slightly more so, likely because visceral fat is more metabolically responsive than subcutaneous fat elsewhere.

The evidence on semaglutide and belly fat specifically reflects this: people with high starting waist circumferences tend to see meaningful reductions, and those reductions track closely with overall weight change. There is no approved semaglutide regimen that exclusively targets the abdomen, and any claim to the contrary is not supported by the licensed product data.

One practical note on routine: Wegovy injection pens need to be kept in the fridge (2–8°C), so many people store them in the fridge door, which also serves as a useful weekly reminder to take the dose. Keeping the habit visible helps with adherence, and adherence is one of the clearest predictors of how much weight loss someone achieves.

Step 3: check which semaglutide product is actually licensed for this

This matters more than it might seem. Semaglutide is sold under different brand names for different conditions. Ozempic contains semaglutide but is licensed by the MHRA for type 2 diabetes, it is not licensed for weight management and should not be used for it. The full picture on licensed semaglutide in the UK is worth reading if you have seen Ozempic mentioned in this context.

Wegovy (the injection) is the licensed weight-management form, and as of 11 June 2026 the MHRA also approved Wegovy tablets, the first oral GLP-1 medicine licensed for weight management in the UK. The NHS medicines page for semaglutide covers both forms and is a reliable reference for what is and is not approved. For anyone considering the injection specifically, the Wegovy overview covers the full licensed schedule and what to expect at each stage.

Wegovy is a prescription-only medicine. A GPhC-registered prescriber reviews every application before anything is dispensed, eligibility is based on BMI, health history and other clinical factors, not just on wanting to lose weight from a particular area. If you are also curious about how Wegovy specifically affects belly fat, the data there builds directly on the points above.

Step 4: consider what comes alongside the medicine

Semaglutide works best alongside dietary changes and increased physical activity, that is written into its licensed indication. Resistance exercise in particular helps preserve muscle tissue during weight loss, which matters both for health and for how the result looks and feels. The question of whether semaglutide burns fat or muscle is a real one worth examining before you start.

For people who do not yet meet the criteria for Wegovy or who want to understand the full range of weight-loss treatments available, it is worth reviewing what else is licensed. The criteria for private prescription differ from NHS thresholds, for adults with a BMI of 30 or above, or 27 and above with a weight-related condition such as high blood pressure or sleep apnoea, a private route through a regulated pharmacy may be available without a referral or waiting list. A clinician still makes that call based on your individual picture.